Vadodara-based Sudeep Pharma has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO).

Vadodara-based Sudeep Pharma files draft papers with SEBI for an IPO, aiming to raise funds through fresh issuance and offer ...

Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order ...

Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to ...

Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined ...

The IPO comprises a fresh issue worth Rs 95 crore and an offer for sale (OFS) of up to 1,00,76,492 equity shares by the ...

As part of celebrating WWMT's 75th birthday, we're catching up with some of the people who have been part of television ...

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant. | Following a ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The pharmaceutical manufacturing market size has grown rapidly in recent years. It substantially expanded from $519.78 ...

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.